Literature DB >> 17214545

Characterisation of Plasmodium falciparum RESA-like protein peptides that bind specifically to erythrocytes and inhibit invasion.

Luis Eduardo Rodriguez1, Ricardo Vera, John Valbuena, Hernando Curtidor, Javier Garcia, Alvaro Puentes, Marisol Ocampo, Ramses Lopez, Jaiver Rosas, Yolanda Lopez, Manuel A Patarroyo, Manuel E Patarroyo.   

Abstract

The Plasmodium falciparum ring-erythrocyte surface antigen (RESA)-like putative protein was identified and characterised. PCR and RT-PCR assays revealed that the gene encoding this protein was both present and being transcribed in P. falciparum strain FCB-2 16 h after erythrocyte invasion. Indirect immunofluorescence studies detected this protein in infected erythrocyte (IE) cytosol in dense fluorescent granules similar to Maurer's clefts at 16-20 h (parasites in ring and trophozoite stages) and very strongly on IE membranes at 22 h, suggesting that it is synthesised during early ring stages (16 h) and transported to the infected red blood cell (RBC) membrane surface during the trophozoite stage (22 h). Western blotting showed that antisera produced against polymerised synthetic peptides of this protein recognised a 72-kDa band in P. falciparum schizont lysate. P. falciparum RESA-like peptides used in normal RBC binding assays revealed that peptides 30326 ((101)NAEKI LGFDD KNILE ALDLFY(120)), 30334 ((281)RVTWK KLRTK MIKAL KKSLTY(300)) and 30342 ((431)SSPQR LKFTA GGGFC GKLRNY(450)) bind with high activity and saturability, presenting nM affinity constants. These peptides contain alpha-helical structural elements, as determined by circular dichroism, and inhibit P. falciparum in vitro invasion of normal RBCs by up to 91%, suggesting that some RESA-like protein regions are involved in intra-erythrocyte stage P. falciparum invasion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17214545     DOI: 10.1515/BC.2007.002

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  2 in total

1.  Purifying and Characterizing Bacterially Expressed Soluble Lactate Dehydrogenase from Plasmodium knowlesi for the Development of Anti-Malarial Drugs.

Authors:  Nurhainis Ogu Salim; Fazia Adyani Ahmad Fuad; Farahayu Khairuddin; Wan Mohd Khairulikhsan Wan Seman; Mohd Anuar Jonet
Journal:  Molecules       Date:  2021-11-01       Impact factor: 4.411

2.  Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model.

Authors:  Jennifer Lambraño; Hernando Curtidor; Catalina Avendaño; Diana Díaz-Arévalo; Leonardo Roa; Magnolia Vanegas; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  J Immunol Res       Date:  2019-12-30       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.